Table 1.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |
---|---|---|---|---|---|---|---|---|
Age | 57 | 33 | 56 | 56 | 73 | 70 | 57 | 56 |
Sex | Female | Men | Female | Men | Female | Female | Men | Female |
Dexamethasone dose (mg/day) | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Days of treatment before admission | 5 | 3 | 6 | 4 | 4 | 5 | 4 | 5 |
PaO2/FiO2 (mmHg) | 305 | 310 | 310 | 324 | 305 | 310 | 305 | 310 |
HRCT Involvement | Severe | Severe | Moderate | Not performed | Severe | Not performed | Severe | Severe |
Ferritin (µg/L) | 378 | 181 | 335 | 579 | 385 | 413 | 133 | 881 |
D-dimer (mg/L) | 0,29 | 0.41 | 1.6 | 0.25 | 0.56 | 0.33 | 0.7 | 0.6 |
CRP (mg/dL) | 205 | 21 | 35 | 63 | 25 | 25 | 133 | 72 |
Treatment | 6MP pulses | 6MP pulses | 6MP pulses | 6MP pulses | Dexamethasone | 6MP pulses | 6MP pulses | 6MP pulses |
HFNO | Anakinra | HFNO | HFNO |
HNFO: high-flow nasal oxygen; CRP: C-reactive protein; HRCT: high resolution computed tomography; 6MP: 6-methylprednisolone.